Clinical Trials for Poseida Therapeutics

Explore 5 clinical trials worldwide

Showing 1-5 of 5 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Poseida Therapeutics

Clinical Trials (5)

A Study to Evaluate the Safety, Tolerability, Cellular Kinetics, and Pharmacodynamics of P-CD19CD20-ALLO1 in Participants With Multiple Sclerosis

PHASE1Recruiting

60 participants

Started: Oct 15, 2025 · Completed: Aug 31, 2032

1 condition2 sponsors1 location

P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell Malignancies

PHASE1Recruiting

120 participants

Started: Apr 16, 2024 · Completed: Mar 31, 2041

10 conditions2 sponsors14 locations

P-BCMA-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Multiple Myeloma

PHASE1Recruiting

231 participants

Started: May 5, 2022 · Completed: Dec 31, 2039

1 condition2 sponsors21 locations

P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors

PHASE1Active, not recruiting

180 participants

Started: Feb 15, 2022 · Completed: Apr 30, 2039

9 conditions1 sponsor14 locations

Long-Term Follow-Up Study for Subjects Treated With P-BCMA-101

PHASE1Active, not recruiting

100 participants

Started: Oct 29, 2018 · Completed: Nov 30, 2032

1 condition2 sponsors13 locations